VJNeurology
The Video Journal of Neurology (VJNeurology) is an independent, global, open-access video journal, dedicated to providing trusted and up-to-date information in order to improve the awareness and understanding of neurology.
Our goal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals, worldwide, on a range of innovative digital media – including video and blog formats.
VJNeurology content will be led by an editorial board of highly respected thought leaders with a combined expertise that spans the spectrum of neurological disorders. All content will be created and published under the guidance of this board of world-leading experts.
Recommendations in the ESO and EANS guidelines on stroke due to spontaneous ICH
Guidance on the reversal of anticoagulation in patients with ICH related to oral anticoagulants
Specific scenarios where intravenous thrombolysis is safe for ischemic stroke patients on DOACs
Arguments against the use of intravenous thrombolysis for ischemic stroke in patients on DOACs
Key emerging data and evolving concepts in prion-like mechanisms of proteinopathies
The alpha-synuclein seed amplification assay and the need to consider Parkinson's beyond movement
Two novel alpha-synuclein missense variants identified in patients with Parkinson's disease
Basic science of movement disorders: recent updates in the field
The use of the 2024 McDonald criteria for the diagnosis of prodromal MS
The relationship between serum biomarkers and spinal cord atrophy in MS
The effect of DMTs on brain volume loss and disability accumulation in MS
The clinical relevance of PRLs and SELs as MRI biomarkers in MS
The impact of iron metabolism on MS disease activity and progression
Highlights from ECTRIMS 2025: updated diagnostic criteria, novel therapies, & more
The risk-benefit ratio of long-term anticoagulation following CVT
Solutions or models of care to improve stroke care globally
Highlights from WSC 2025 beyond trial updates: cardiac imaging, the impact of AI, & more
The interpretation of non-inferiority trials in stroke research
The potential of adipose mesenchymal stem cells in treating acute ischemic stroke
The existing evidence for Factor XIa inhibition in secondary stroke prevention: Phase II trials
The mechanistic rationale for targeting Factor XI for secondary acute ischemic stroke prevention
Effect of colchicine on cognitive outcomes after acute ICH: secondary analysis of COVASC-ICH
The effect of individualized recurrence risk communication on health behaviors in ischemic stroke
The safety and efficacy of additional cycles of cladribine in MS: insights from a real-world study
Novel strategies being explored for the secondary prevention of non-cardioembolic stroke
An update on studies investigating Factor XIa inhibitors for secondary stroke prevention
Assessing treatment efficacy in MS and NMOSD: moving beyond relapse rates
Addressing structural determinants of health in MS: improving patient care and outcomes
Further findings from a Phase I trial of CAR-T in MS: patient-reported outcomes
The expansion of CAR T-cells into the bloodstream of patients with MS: insights from a Phase I trial